Understanding Annexes VII-X

Avoiding obstacles with REACH Annexes VII-X Posted by Dr. David Howes, Expert Consultant in Chemical Legislation and Chemistry, Covance In the EU, the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulations address the manufacturing and import of chemicals to ensure they are safe for human health and the environment. …

Step inside Mechelen: a day in the life of a regional study coordinator’s project management role

Elien is a Senior Regional Study Coordinator (RSC), which is an associate project manager role, housed in our growing Mechelen, Belgium office for Covance Central Laboratory Services (CLS). She shared a glimpse inside a typical day as a Regional Study Coordinator, a role that manages local laboratory operations within our …

Covance Shanghai strengthens safety pharmacology capabilities for in-house IND packages in Asia

Covance Shanghai is pleased to announce an expansion of its general toxicology capabilities to include safety pharmacology studies, allowing our Asia-Pacific clients to more easily complete their IND requirements for CFDA regulations. What are the new safety pharmacology offerings? The general tox team in Shanghai is now capable of running …

Preserving lifecycles: renewing established pesticides

The regulation that governs the marketing, sale, and use of pesticides is just a fact of life, but the standards imposed are constantly evolving as our scientific insight and knowledge increases. This series of informational blogs is designed to examine how existing active substances (ASs) are managed through the current …

From PhD to clinical trials project management: Ana’s career shift quickly delivers results

Ana’s passion for biomedical sciences brought her to Covance as a Regional Study Coordinator (RSC) earlier this year. She said after working in R&D and chemistry, shifting to a project management role presented an opportunity to develop different skills and realize an immediate impact on patients’ lives. The opportunity to …

Listening to – and learning from – the voice of the patient

Patient recruitment represents the biggest challenge in clinical trials. From general patient identification and participation to reducing screen failure rate or limiting patient drop out after enrollment, drug developers face many massive pain points to initiate their clinical trials.   Patient recruitment and retention continue to be the biggest challenge in …

Future-proofing residue analysis services

As the regulatory landscape across the globe is rapidly evolving, more sophisticated requirements must be met by registrants and scientists. In parallel, scientific advances have impacted previous methodologies that were once seen as cutting edge but now may fail to adequately address new regulatory challenges. Clients should consider techniques to …